The cell growth inhibition activities of OSU-HDAC-44 were assessed in three human NSCLC cell lines including A549 (p53 wild-type), H1299 (p53 null), and CL1-1 (p53 mutant). Here, HDAC9 is linked to non-small cell lung carcinoma.